US Lawmakers Propose Generic Biotech Drug Plan

WASHINGTON, March 11 (Reuters) - U.S. lawmakers unveiled a bipartisan proposal on Wednesday to allow government approval for cheaper copies of biotechnology medicines that cost as much as tens of thousands of dollars per year.

Representative Henry Waxman, joined by a Democratic colleague and two Republicans, said biotech drugs were the fastest-growing and most expensive part of the nation's prescription drug bill. Generic versions could provide safe alternatives while saving money for patients, employers, insurers and the federal government, the lawmakers said.

Arizona Internet Marketing
Arizona Biotechnology Marketing
Biotechnology News